(Q22242308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

New chemotherapeutic approaches in the treatment of Lyme borreliosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

0 references

0 references

3

J J Halperin

J J

Halperin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1

B J Luft

B J

Luft

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

D J Volkman

2

D J

Volkman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

R J Dattwyler

series ordinal

4

author given names

R J

author last names

Dattwyler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

language of work or name

English

0 references

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

9 October 2019

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1 Lyme Disease

0 references

page(s)

352-361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3056203%20AND%20SRC:MED&resulttype=core&format=json

The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1988.TB31869.X

Treatment of the Early Manifestations of Lyme Disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

7 January 2021

Successful parenteral penicillin therapy of established Lyme arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

7 January 2021

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

7 January 2021

Ceftriaxone as effective therapy in refractory Lyme disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

7 January 2021

The penetration of ceftriaxone into synovial fluid of the inflamed joint

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

7 January 2021

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB31869.X

7 January 2021